Top Tips and Ideas for Compliance Professionals - E-Book

Source: PharmaManufacturing.com

Jul 29, 2013

totalbiopharma

Regulatory non compliance costs the pharma industry billions in fines, audits and much more each year. To avoid these fines and bad reputation pharma companies rely heavily on their compliance teams, who provide oversight from R&D to the very end of a product cycle. 

Industry representatives share what they find the biggest challenges they face in their day to day work. They also give insight and thoughts on the implications and how to overcome them.


•Britta Luescher, Compliance Director, Novartis International AG 
•Dr. Michael Bartke, Director Compliance, Daiichi Sankyo
•Ana Gonzalez Prada, EMEA Corporate Counsel,  Ethics & Compliance, Baxter Healthcare
•Nick Broughton, Managing Director, Pharmaceuticalethics.com
•Dr. Wolfgang Beck, Associate Partner, WMQMS Ltd.
•Niklas Pieper, Senior Corporate Compliance Counsel, Bayer Healthcare

Download here

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments